|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Allogene Therapeutics (NASDAQ: ALLO) through any online brokerage.
The latest price target for Allogene Therapeutics (NASDAQ: ALLO) was reported by JMP Securities on October 12, 2021. The analyst firm set a price target for 27.00 expecting ALLO to rise to within 12 months (a possible 70.67% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Allogene Therapeutics (NASDAQ: ALLO) is $15.82 last updated Fri Oct 22 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Allogene Therapeutics.
Allogene Therapeutics’s $Q3 earnings are confirmed for after-market on $November 3, 2021.
There is no upcoming split for Allogene Therapeutics.
Allogene Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.